News
News
- BridgeBio Pharma and Affiliate Origin Biosciences Announce FDA Approval of NULIBRY™ (fosdenopterin), the First and Only Approved Therapy to Reduce the Risk of Mortality in Patients with MoCD Type A
14:00 - GlobeNewswire - EBIX ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Ebix, Inc.
02/27/2021 / 19:48 - GlobeNewswire - BTBT SHAREHOLDER DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Against Bit Digital, Inc.
02/27/2021 / 19:03 - GlobeNewswire - Kaskela Law LLC Announces Shareholder Class Action Lawsuit Against Ebix, Inc. (EBIX) and Encourages Long-Term EBIX Investors to Contact the Firm
02/27/2021 / 17:30 - GlobeNewswire - PTA-PVR : Readcrest Capital AG: Release according to Article 40, Section 1 of the WpHG
02/22/2021 / 15:28 - pressetext - PTA-DD: Readcrest Capital AG: Managers' transactions announcement according to article 19 MAR
02/22/2021 / 13:28 - pressetext - PTA-PVR : Readcrest Capital AG: Release according to Article 40, Section 1 of the WpHG
02/22/2021 / 13:24 - pressetext - PTA-PVR : Readcrest Capital AG: Release according to Article 40, Section 1 of the WpHG
02/22/2021 / 10:35 - pressetext - PTA-PVR : Readcrest Capital AG: Release according to Article 40, Section 1 of the WpHG
02/22/2021 / 10:35 - pressetext - PTA-News: Frequentis AG: FREQUENTIS and Bayanat to support Dubai Air Navigation Services with airport contingency plans
02/22/2021 / 09:02 - pressetext
Real-time